Study
Aggregation and Propagation of α-Synuclein in Parkinson's Disease: A Bibliometric Perspective
A review of research trends on α-synuclein helps seniors understand ongoing efforts to treat the biological root of Parkinson’s.
Summary
In plain language
A review examining how alpha-synuclein protein aggregation and cell-to-cell spread contributes to Parkinson's disease progression, with implications for developing disease-modifying treatments.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This review details the mechanisms of alpha-synuclein aggregation and propagation in Parkinson's disease. The research examines how toxic protein species form, spread between neurons, and contribute to neurodegeneration, informing therapeutic development.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Aggregation and Propagation of α-Synuclein in Parkinson's Disease: A Bibliometric Perspective
Published October 2025
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored January 20, 2026 using rubric v5_2025-02-01.
Assessment
The study provides a valuable overview of research trends in α-synuclein aggregation in Parkinson's disease. While the bibliometric approach is useful for identifying research directions, it lacks experimental evidence and detailed statistical validation. The study is transparent and relevant, with a clear conflict of interest disclosure.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 6.7/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 7.5/10 | |
| Reporting completeness | 7.5/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 5.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 7.5/10 |
Additional Notes
The study could be improved by providing access to raw data and more detailed statistical analyses. Additionally, addressing potential biases in data interpretation would enhance its credibility.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.